OTHER GROUP COMPANIES
market

IOL Chemicals & Pharma logs ~48% y-o-y decline in Q1FY23 PAT

Company achieved an EBITDA Margin of 10.70% in Q1FY23 as compared to 8.6% in Q4FY22.

August 11, 2022 9:24 IST | India Infoline News Service
IOL Chemicals and Pharmaceuticals Limited, a leading manufacturer of pharmaceutical (APIs) and specialty chemicals reported results for the first quarter ended June 30, 2022.

The company has reported a Total income of Rs570.20 crore in Q1FY23 as against Rs579.40 crore in the previous quarter, down by 1.6% sequentially. However, on a y-o-y basis, the company registered a growth of 8.78% against Rs524.20 crore in Q1FY22.

For Q1FY23, the company logged an EBITDA of Rs61.20 crore, up by 22.20% against Rs50.10 crore in the previous quarter. While on a y-o-y basis, EBITDA declined by 47.20% against Rs115.90 crore in Q1FY22.

Company achieved an EBITDA Margin of 10.70% in Q1FY23 as compared to 8.6% in Q4FY22.

IOL’s PAT in Q1FY23 stood at Rs34.90 crore as compared to Rs27.80 crore in Q4FY22, registering a growth of 25.50% yoy. PAT for Q1FY22 was reported at Rs67 crore, registering a decline of 47.91% yoy.

At around 9.27 AM, IOL Chemicals was trading at Rs354.30 up by Rs5.7 or 1.64% from its previous closing of Rs348.60 on the BSE. The scrip opened at Rs348.60.

Invest wise with Expert advice

FEATURED ARTICLE

BLOGS

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp